Invex Therapeutics Ltd
IXC
Company Profile
Business description
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.
Contact
38 Rowland Street
Level 1
Subiaco WA 6008
AUST: +61 863820137
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
Stocks News & Analysis
stocks
These 3 ASX companies share something powerful with Uber
Situations like this are rare and can lead to impressive growth and daunting moats.
stocks
Our take on ANZ earnings and the outlook for the dividend
Is the bank paying too much for home loan growth?
stocks
Any benefit from acquisition of ASX listed company’s business units?
Private equity strikes again but it is difficult to conclude if shareholders are winners from the deal.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,991.00 | 85.70 | -1.06% |
| CAC 40 | 8,131.41 | 55.73 | 0.69% |
| DAX 40 | 18,498.38 | 68.33 | 0.37% |
| Dow JONES (US) | 39,056.39 | 172.13 | 0.44% |
| FTSE 100 | 8,354.05 | 40.38 | 0.49% |
| HKSE | 18,536.10 | 222.24 | 1.21% |
| NASDAQ | 16,302.76 | 29.80 | -0.18% |
| Nikkei 225 | 38,164.71 | 37.66 | -0.10% |
| NZX 50 Index | 11,746.59 | 36.30 | -0.31% |
| S&P 500 | 5,187.67 | 0.03 | -0.00% |
| S&P/ASX 200 | 7,718.80 | 85.70 | -1.10% |
| SSE Composite Index | 3,153.11 | 24.63 | 0.79% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 6.76% |
| Imugene Ltd IMU | 0.07 | 0.00 | -4.67% |
| Vicinity Centres VCX | 1.93 | 0.01 | -0.39% |
| Strike Energy Ltd STX | 0.24 | 0.02 | 7.95% |
| Pilbara Minerals Ltd PLS | 4.17 | 0.01 | -0.24% |
| Sigma Healthcare Ltd SIG | 1.29 | 0.01 | -0.39% |
| Liontown Resources Ltd LTR | 1.39 | 0.06 | 4.51% |
| Westpac Banking Corp WBC | 26.32 | 1.58 | -5.65% |
| Telstra Group Ltd TLS | 3.64 | 0.02 | -0.41% |
| South32 Ltd S32 | 3.61 | 0.05 | -1.23% |